Daniel Booser

Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

Leming Shi, Weiwei Shi, Mauro Delorenzi, 2010, Breast Cancer Research.

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.

Lajos Pusztai, Christos Sotiriou, Kenneth R Hess, 2007, The Lancet. Oncology.

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

Yuan Qi, Lajos Pusztai, Charles Coutant, 2011, Journal of the National Cancer Institute.

A Phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma

G. Hortobagyi, F. Ames, V. Valero, 2003, Cancer.

Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma

Roman Rouzier, Lajos Pusztai, G. Hortobagyi, 2005, Cancer.

Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer.

Razelle Kurzrock, D. Booser, R. Kurzrock, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Women age < or = 35 years with primary breast carcinoma: disease features at presentation.

Kristine Broglio, G. Hortobagyi, V. Valero, 2005, Cancer.

Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry.

Yuan Qi, Jie Zhang, Christos Hatzis, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.